Client login

Pharmaceutical Development / 5Ps Driving Trends in Small Molecule Pharmaceutical Development

Article

5Ps Driving Trends in Small Molecule Pharmaceutical Development

Almac Pharma Services’ VP of Technical Operations, John McQuaid discusses the growing requirements and driving trends associated with small molecule drug development.

Click here to read Q&A.

View Resource

Our Expert

John McQuaid, President & Managing Director, Craigavon, Almac Pharmaceutical Development

Almac Pharmaceutical Drug Product Development

Addressing the increasing pressure on pharmaceutical companies to bring clinical candidates through their pipeline faster and with greater efficiency, Almac Pharma Services provide expert pharmaceutical drug product development solutions.

Our scientists can develop clinical candidates into optimum formulations and manufacture solid oral dose products for all stages of clinical trials.

From developing a fit-for-purpose formulation for First-in-Human trials, to scaling up for late phase trials.

Learn More

You may also be interested in

Article

Safeguarding Potency: Innovative Containment Strategies for HPAPI Manufacturing

Article

Strategic outsourcing in pharma: building resilient partnerships for a complex future

Simon Wright

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies

Please complete this form to view the Article

Safeguarding Potency: Innovative Containment Strategies for HPAPI Manufacturing

Strategic outsourcing in pharma: building resilient partnerships for a complex future